US 11992506
Stem cell derived pancreatic islet differentiation
granted A61KA61K31/4704A61K35/39
Quick answer
US patent 11992506 (Stem cell derived pancreatic islet differentiation) held by Vertex Pharmaceuticals Incorporated expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/4704, A61K35/39, A61K38/28, A61P